Vertex Pharmaceuticals | Azione

Prezzo Delle Azioni
480.13
Cambio Giornaliero
-2.92 -0.60%
Mensile
1.26%
Annuale
1.19%
Q1 Previsione
462.12




Azione Cambiamento Data
AbbVie USD 4.95B 13M 2025-12
Acadia Pharmaceuticals USD 34.67M 5.57M 2025-12
Agios Pharmaceuticals USD 32.92M 886K 2025-12
Alnylam Pharmaceuticals USD 82.72M 7.34M 2025-12
Amgen USD 6.22B 121M 2025-12
Arrowhead Research USD -173.08M 173.08M 2024-12
Biogen USD 2.17B 41.3M 2025-12
BioMarin Pharmaceutical USD 1.3B 83.29M 2025-12
Bristol-Myers Squibb USD 2.76B 21M 2025-09
Gilead Sciences USD 1.78B 40M 2025-09
Incyte USD 101.06M 17.61M 2025-12
Insmed USD 132.07M 11.1M 2025-12
Ionis Pharmaceuticals USD 10.47M 1.99M 2025-09
J&J USD 14.19B 45M 2025-12
Merck USD 6.44B 157M 2025-09
Moderna USD 332M 92M 2025-09
Neurocrine Biosciences USD 69M 300K 2025-12
Novartis USD 6.42B 114M 2025-09
Pfizer USD 11.47B 201M 2025-09
PTC Therapeutics USD 79.65M 26.96M 2025-12
Puma Biotechnology USD 9.48M 885K 2025-09
Regeneron Pharmaceuticals USD 3.2B 53.6M 2025-12
Roche Holding CHF 7.6B 9M 2025-06
Sanofi EUR 22.69B 1.81B 2025-12
Sarepta Therapeutics USD 914.74M 162.42M 2025-12
Ultragenyx Pharmaceutical USD 52.2M 5.7M 2025-09
United Therapeutics USD 183.1M 6.6M 2025-12
Vertex Pharmaceuticals USD 1.69B 60M 2025-12


Vertex Pharmaceuticals Azione - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Feb 2026.